Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6Breast Neoplasms 2Small Cell Lung Carcinoma 1Recurrence 1Prostate Cancer Metastatic 1Neoplasm Metastasis 1Metastatic Breast Cancer With Intracranial Metastases 1Lung Neoplasms 1Hormone-Resistant Prostate Cancer 1Diarrhea 1Castrate-resistant Metastatic Prostate Cancer 1Carcinoma, Transitional Cell 1Brain Neoplasms 1

Interventions

cabazitaxel 1XRP6258 1Prednisone 1Granulocyte Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Castrate-resistant Metastatic Prostate Cancer × XRP6258 × Clear all
NCT01750866 2013-10-16

Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer

Case Comprehensive Cancer Center

Phase 2 Withdrawn
Genitourinary

Castrate-resistant Metastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡